SERUM CONCENTRATIONS OF TRIMETHYLPSORALEN AFTER ORAL ADMINISTRATION  by Stolk, L.M.L. et al.
0022-202X/ 83/ 8103-0289$02.00/ 0 
T H E JOURNAL OF I NVEST I GATI VE DERMATOL OGY, 81:289-290, 1983 
Copyright © 1983 by T he Williams & Wilkins Co. 
SERUM CONCENTRATIONS OF TRIMETHYLPSORALEN 
AFTER ORAL ADMINISTRATION 
T o t he Editor: 
With in te rest we have read in t his J ournal t he paper of Chakrabart i 
et a! ent itled "Determination of T rimethylpsoralen in Blood, Oph-
t halmic Fluids, and Skin" (79:374-377, 1982). These authors reported 
to have found only one paper that deals wit h the determination of 
t rimethylpsoralen (TMP) after oral administration. However we [1) 
have also determined serum levels of TMP. 
T he analytical method we used was just like the method of Chakra-
bart i eta!, based on reverse-phase high-performance liquid chromatog-
raphy. After oral administration of di ffe rent doses of TMP <.rangmg 
from 40-400 mg) as Trisoralen sugar tablets (Elder Co., OhiO) to 4 
vit iligo patients, we measured hourly t he serum concent rations up to 5 
hours afte r administration. Only very small amounts of T MP up to 31 
ng/ ml could he detected in t he serum. This is in sharp cont rast to the 
resul ts of Chakrabarti et a!, who measured much higher TMP peak 
concentrations (140- 800 ng/ml) 1-2 hours after oral administration of 
30 mg TMP. 
The same results were obtained by us [2) after oral administration 
of 400 mg to another 6 vi t iligo patients. Moreover, about half of t he 
administered TMP was recovered unchanged in the feces, collected 
unt il 72 hours after administration, indicating poor absorpt ion. Poor 
absorption is consistent wit h t he extremely poor water solubil ity of 
TM P: 15 Jig/ lite r at room temperature. 
When we determined TMP concentrations in whole blood instead 
of serum, essent ially t he same results were obtained. 
We also compared t he half-lives of TMP and 8-methoxypsoralen (8-
MOP) in rabbits afte r int ravenous administration. In comparison wit h 
8-MOP (15- 20 minutes) t he half- life of TMP was very short : 3- 5 
minutes. 
Our conclusions a re t hat both poor absorpt ion and rapid elimination 
might be responsible fo r the low T MP serum concentrations and t he 
t herapeutic ineffectiveness of TMP . T herefore t he discrepancy between 
our resul ts and those found by Chakrabart i eta! a re difficult to expla in. 
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REPLY 
The letter wri tten by Drs. Stolk, Siddiqui, and Cormane to the 
Edito r of The J ournal of Investigative Dermatology was brought to our 
attent ion recently. We sincerely regret the fact t hat we did not cite t he 
work of these investigators [1) in our recent publication. In order to 
determine the reason for t his oversight, we have just completed a 
defin itive search at t he National Library of Medicine, where we discov-
ered t hat t he listing of the paper by Stolk et al appeared in t he April 
1982 issue of t he Cumulative Index Medicus. We also understand that 
it was put in to the computer search system at about the same t ime. We 
had the major portion of our bibliographical research completed at t he 
end of March 1982. We have now read the art icle and we regret that 
we did not have t he info rmation in t ime to have included our comments 
in our paper. However, we would like to comment briefly at this t ime. 
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LETTERS TO THE EDITOR 
Stolk eta! [1) determined serum levels of t rimethylpsoralen (TMP) 
in 4 patients and found these levels to be very low (0-6 ng/ml ) when 
the dosage was up to 200 mg per patient (body weight 63-73 kg). Only 
afte r the administration of 300 and 400 mg of t he drug to a patient 
(body weight 74 kg), could t hey find maximum serum TMP levels of 
29 and 31 ng/ ml. T hese aut hors cla im that they recovered 100% of t he 
administered drug from feces and that t he drug is not absorbed because 
of t he poor water solubility of TMP. Also t hey determined the biologic 
half- life of the T MP in the rabbit and found it to be very short (3- 5 
minutes) . 
We would like to bring the fo llowing facts to t he attent ion of Drs. 
Stolk, Siddiqui , and Cormane. (a) T he high-perfo rmance liquid chro-
matography method that they used was not identical wit h our method. 
We extracted TMP from blood, t issues, and body fluids at pH 9 (when 
t he lactone ring is open, and hence, the molecule is hydrophilic), 
whereas Stolk et a! did not ment ion t he condit ions under which t he 
drug was extracted. (b) T heir extracting solvent mi.xturc was di ffer~n t 
from ours. (c) T heir reverse phase column matn x and the elutmg 
solvent composition were entirely di ffe rent t han ours. (d) These aut hors 
did not provide any recovery data afte r t he addit ion of different 
amounts of T MP to a fixed amount of serum, whereas we clearly 
provided t hese data. . . 
Contrary to t he observations of Stolk et al, our results mdtcate t hat 
t he drug is absorbed from t he gut when administered orally and the 
peak blood levels occurred either at 1 hour, 2 hours, or more. We 
demonstrated t hat t he drug is distributed in most of the guinea pig 
organs, including skin, epidermis, and opht halmic fluids. In addit ion, 
we isolated at least 4 metabolites of TMP from blood, liver, and other 
organs of the guinea pig [3). We also demonstrate~ t hat t~e material 
isolated from patient's blood afte r oral TMP adminiStratiOn has t he 
same mobility as authent ic T MP on thin - Ja~er plat~s and ~hat t he 
isolated material produced erythema on t he skm of hairless mice afte r 
topical application and UV A irradiation. . . 
Review of t he lite rature involving TMP absorptiOn, metabolism, and 
the clinical effectiveness of the drug when orally administered indicates 
t he fo llowing: Murata et a l [4) studied absorption, excretion, distribu-
t ion and metabolism of [3H] t rioxsalen in t he rat and found t hat peak 
blood levels of up to 4 llg/ g (4000 ng/ ml) were reached in 1 hour after 
oral administration. They found also that the concentrations of t he 
drug in organs such as liver, spleen, kidney, and skin were of t he same 
order of magnitude (> 1 Jig/ g) . These investigators isolated 60% of the 
administered radioactivity from feces and 0.24 % of t he admm1stered 
drug from urine. These observations a re similar to our findin gs. In 
addi t ion Mandula Pathak and Dudek [5) ident ified 4,8-dimethyl-5'-carbox~sora len i~ mouse ~nd human urine after ingestion of trioxsa-
len, indicating absorption and in vivo m~tabolism of TMP: T hese 
authors [6] also ident ified several metabolites of TMP by thm-l.ayer 
chromatography after in vit ro metabolism of the drug, usmg a mtcro-
somal preparation. These results clearly indicate that TMP is absorbed 
and t he biotransformation occurs both in vivo and in vit ro. Our results 
are consistent wit h t hese observations. 
Finally, Kaidbey and Kligman [7) reported photopigmenta~ion and 
melanogenesis in patients afte r oral ingestion of 90 mg of t n oxsalen 
and irradiation with UV A. Furthermore, Sehgal reported t hat orally 
administered t rioxsalen and exposure to sunlight seemed to be an 
effective and safe t reatment fo r vit iligo areata in children, producing 
no cutaneous or systemic side effects [8- 10] . 
Our observat ions t hat TMP is absorbed, metabolized, and produces 
photochemotherapeut ic reactions are consistent wit h t he observations 
of Kaidbey and Kligman [7], as well as t hose of Sehgal [8-10] and our 
own clinical observations. 
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